Anna Greka, M.D., Ph.D.
Board Member
Ovid Therapeutics Inc. (OVID)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Anna Greka, M.D., Ph.D.
Anna Greka, M.D., Ph.D. is recorded as Board Member at Ovid Therapeutics Inc. (OVID). Ovid Therapeutics Inc. reported in an 8-K filed June 3, 2026 that Anna Greka, M.D., Ph.D. was appointed Class III director, effective June 15, 2026.
“the appointment of Anna Greka, M.D., Ph.D., as a Class III director of the Company, with her term expiring at the Company's 2029 annual meeting of stockholders.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2026-06-15–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Ovid Therapeutics Inc.
Other people whose current roles at this company are on record from its filings.
- Margaret "Meg" Alexander CEO, COO, Board Member
- Margaret Alexander CEO, COO, Board Member
- Jeremy M. Levin Chairman
- Charles Carter CFO
- Jeffrey Rona CFO, Chief Accounting Officer
- Dr. Kevin Fitzgerald, Ph.D. Board Member
- Dr. Robert Michael Poole Board Member
- Stelios Papadopoulos, Ph.D. Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.